Please try another search
For the nine months ended 30 September 2017, Omega Protein Corporation revenues decreased 16% to $257.8M. Net income applicable to common stockholders decreased 50% to $14.2M. Revenues reflect Animal Nutrition segment decrease of 28% to $115.1M. Net income also reflects Human Nutrition segment income decrease of 61% to $23.1M, Unallocated segment loss increase of 9% to $14M. Dividend per share totaled to $0.15.
Period Ending: | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Total Revenue | 90.28 | 93.92 | 73.57 | 84.58 |
Gross Profit | 13.79 | 22.51 | 20.19 | 22.64 |
Operating Income | 0.69 | 12.05 | 9.8 | 7.99 |
Net Income | 0.92 | 7.36 | 6.08 | 4.31 |
Period Ending: | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Total Assets | 442.48 | 432.18 | 420.36 | 427.87 |
Total Liabilities | 91.64 | 83.45 | 79.13 | 91.18 |
Total Equity | 350.84 | 348.73 | 341.23 | 336.69 |
Period Ending: | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 23.9 | 1.17 | 0.56 | 93.73 |
Cash From Investing Activities | -36.3 | -26.63 | -13.18 | -36.28 |
Cash From Financing Activities | -4.06 | -2 | -1.21 | -20.69 |
Net Change in Cash | -16.46 | -27.45 | -13.83 | 36.75 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review